PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
AHSG 176 Target Disease Breast Cancer 173,695 4 0.00 -0.99 0.02 0.55
AHSG 176 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.01 0.55
AHSG 176 Target Disease Glioblastoma 17,933 1 0.00 -1.00 0.01 0.57
AHSG 176 Target Disease Inflammation 252,734 24 0.00 -0.93 0.14 0.59
AHSG 176 Target Target BMP-2 3,889 1 0.00 -1.00 0.01 0.62
AHSG 176 Target Target AGP 2,006 4 0.01 -0.99 0.02 0.68
AHSG 176 Target Disease Diabetic Retinopathy 14,494 1 0.00 -1.00 0.01 0.58
AHSG 176 Target Target APOC1 126 1 0.01 -0.99 0.01 0.72
AHSG 176 Target Disease Lung Cancer 91,416 2 0.00 -0.99 0.01 0.55
AHSG 176 Target Target BCHE 1,167 1 0.00 -1.00 0.01 0.65
AHSG 176 Target Target C7 7,027 4 0.00 -0.99 0.02 0.64
AHSG 176 Target Disease Scoliosis 14,102 1 0.00 -1.00 0.01 0.58
AHSG 176 Target Target Alpha-1 AntiChymotrypsin 1,460 2 0.00 -0.99 0.01 0.67
AHSG 176 Target Target BMP-4 1,255 1 0.00 -1.00 0.01 0.65
AHSG 176 Target Disease Dyslipidemia 15,225 2 0.00 -0.99 0.01 0.60
AHSG 176 Target Target EGF 27,487 1 0.00 -1.00 0.01 0.56
AHSG 176 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.01 0.56
AHSG 176 Target Disease Malnutrition 27,452 1 0.00 -1.00 0.01 0.56
AKT2 873 Target Disease Hyperlipoproteinemia 2,954 1 0.00 -1.00 0.00 0.59
AKT2 873 Target Disease Osteoporosis 46,215 2 0.00 -1.00 0.00 0.54
AKT2 873 Target Disease Lung Carcinoma 13,423 1 0.00 -1.00 0.00 0.55
AKT2 873 Target Disease Multiple Myeloma 24,594 1 0.00 -1.00 0.00 0.54
AKT2 873 Target Disease Viral Disease 2,087 1 0.00 -1.00 0.00 0.60
AKT2 873 Target Target AKT3 293 164 0.32 -0.60 0.56 0.88
AKT2 873 Target Disease Stroke 146,992 4 0.00 -1.00 0.00 0.53
AKT2 873 Target Target ERBB4 994 2 0.00 -1.00 0.00 0.65
AKT2 873 Target Disease Bladder Cancer 21,509 3 0.00 -1.00 0.00 0.57
AKT2 873 Target Disease Infection 766,637 14 0.00 -0.99 0.02 0.52
AKT2 873 Target Disease Hyperglycemia 28,168 9 0.00 -0.99 0.01 0.59
AKT2 873 Target Disease Skin Cancer 11,561 4 0.00 -1.00 0.00 0.59
AKT2 873 Target Disease Hypertriglyceridemia 7,877 5 0.00 -1.00 0.01 0.61
AKT2 873 Target Disease Prostate Cancer 71,064 20 0.00 -0.99 0.02 0.59
AKT2 873 Target Disease Herniated Discs 393 1 0.00 -1.00 0.00 0.65
AKT2 873 Target Disease Schizophrenia 77,034 2 0.00 -1.00 0.00 0.52
AKT2 873 Target Target Aurora Kinase A 196 1 0.00 -1.00 0.01 0.66
AKT2 873 Target Disease Irritable Bowel Syndrome 8,230 1 0.00 -1.00 0.00 0.56
AKT2 873 Target Disease Ileus 9,091 1 0.00 -1.00 0.00 0.56
AKT2 873 Target Disease Fracture 111,575 1 0.00 -1.00 0.00 0.50
AKT2 873 Target Target CCL4 5,638 1 0.00 -1.00 0.00 0.57
AKT2 873 Target Target Beta-Tubulin 4,870 1 0.00 -1.00 0.00 0.58
AKT2 873 Target Disease Polycystic Ovarian Syndrome 1,615 1 0.00 -1.00 0.00 0.61
AKT2 873 Target Disease Ovarian Cancer 33,996 45 0.01 -0.97 0.05 0.64
AKT2 873 Target Disease Warts 5,574 1 0.00 -1.00 0.00 0.57
AKT2 873 Target Target Phospholipase A2 13,400 1 0.00 -1.00 0.00 0.55
AKT2 873 Target Target Insulin-Like Growth Factor 1 Receptor 1,052 1 0.00 -1.00 0.00 0.63
AKT2 873 Target Target Adiponectin 11,994 12 0.00 -0.99 0.01 0.63
AKT2 873 Target Target ERK1 18,374 21 0.01 -0.99 0.02 0.63
AKT2 873 Target Target ETS1 539 1 0.00 -1.00 0.00 0.64
AKT2 873 Target Disease Basal Cell Carcinoma 7,953 1 0.00 -1.00 0.00 0.56
AKT2 873 Target Disease Leukemias 14,152 1 0.00 -1.00 0.00 0.55